A20 is a negative regulator of IFN regulatory factor 3 signaling

Journal of Immunology

Volumn 174, Issue 3, 2005, Pages 1507-1512

  Saitoh, Tatsuya ^a   Yamamoto, Masahiro ^b   Miyagishi, Makoto ^d,e   Taira, Kazunari ^d,e   Nakanishi, Makoto ^f   Fujita, Takashi ^g   Akira, Shizuo ^b,c   Yamamoto, Naoki ^a   Yamaoka, Shoji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; DOUBLE STRANDED RNA; I KAPPA B KINASE; INTERFERON REGULATORY FACTOR 3; PROTEIN A20; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIRD DISEASE; DIMERIZATION; DNA RESPONSIVE ELEMENT; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 12444287911     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.3.1507     Document Type: Article

References (37)

1. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255.
2. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623.
3. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335.
4. Servant, M. J., N. Grandvaux, and J. Hiscott. 2002. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 64:985.
5. 386 of interferon regulatory factor 3 as critical targets for inducible phosphorylation that determines activation. J. Biol. Chem. 279:9698.
6. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491.
7. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148.
8. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16:3.
9. Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira. 2003. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4:1144.
10. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 198:1043.
11. Oshiumi, H., M. Sasai, K. Shida, T. Fujita, M. Matsumoto, and T. Seya. 2003. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J. Biol. Chem. 278:49751.
12. Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171:4304.
13. Beyaert, R., K. Heyninck, and S. Van Huffel. 2000. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis. Biochem. Pharmacol. 60:1143.
14. Buwitt, U., C. Koch, D. Tatje, J. Hoppe, and G. Gross. 1992. Platelet-derived growth factor isoforms AA, AB, and BB differentially activate poly r(I):r(C)-induced genes in human fibroblast FS4 cells. DNA Cell Biol. 11:641.
15. Donze, O., J. Deng, J. Curran, R. Sladek, D. Picard, and N. Sonenberg. 2004. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 23:564.
16. Evans, P. C., H. Ovaa, M. Hamon, P. J. Kilshaw, S. Hamm, S. Bauer, H. L. Ploegh, and T. S. Smith. 2004. A20, a regulator of inflammation and cell survival, has deubiquitinating activity. Biochem. J. 378:727.
17. Lee, E. G., D. L. Boone, S. Chai, S. L. Libby, M. Chien, J. P. Lodolce, and A. Ma. 2000. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289:2350.
18. O'Reilly, S. M., and P. N. Moynagh. 2003. Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. Biochem. Biophys. Res. Commun. 303:586.
19. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1087.
20. Tojima, Y., A. Fujimoto, M. Delhase, Y. Chen, S. Hatakeyama, K. Nakayama, Y. Kaneko, Y. Nimura, N. Motoyama, K. Ikeda, et al. 2000. NAK is an IκB kinase-activating kinase. Nature 404:778.
21. Miyagishi, M., and K. Taira. 2002. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:497.
22. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:6668.
23. Saitoh, T., H. Nakano, N. Yamamoto, and S. Yamaoka. 2002. Lymphotoxin-β receptor mediates NEMO-independent NF-βB activation. FEBS Lett. 532:45.
24. Zhang, S. Q., A. Kovalenko, G. Cantarella, and D. Wallach. 2000. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity 12:301.
25. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677.
26. Kinjyo, I., T. Kanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583.
27. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191.
28. Brint, E. K., D. Xu, H. Liu, A. Dunne, A. N. McKenzie, L. A. O'Neill, and F. Y. Liew. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5:373.
29. Sakaguchi, S., H. Negishi, M. Asagiri, C. Nakajima, T. Mizutani, A. Takaoka, K. Honda, and T. Taniguchi. 2003. Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shock. Biochem. Biophys. Res. Commun. 306:860.
30. Heylbroeck, C., S. Balachandran, M. J. Servant, C. DeLuca, G. N. Barber, R. Lin, and J. Hiscott. 2000. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J. Virol. 74:3781.
31. Senger, K., M. Merika, T. Agalioti, J. Yie, C. R. Escalante, G. Chen, A. K. Aggarwal, and D. Thanos. 2000. Gene repression by coactivator repulsion. Mol. Cell 6:931.
32. Juang, Y. T., W. C. Au, W. Lowther, J. Hiscott, and P. M. Pitha. 1999. Lipopolysaccharide inhibits virus-mediated induction of interferon genes by disruption of nuclear transport of interferon regulatory factors 3 and 7. J. Biol. Chem. 274:18060.
33. Heyninck, K., D. De Valck, W. Vanden Berghe, W. Van Criekinge, R. Contreras, W. Fiers, G. Haegeman, and R. Beyaert. 1999. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J Cell Biol. 145:1471.
34. Meylan, E., K. Burns, K. Hofmann, V. Blancheteau, F. Martinon, M. Kelliher, and J. Tschopp. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5:503.
35. Klinkenberg, M., S. Van Huffel, K. Heyninck, and R. Beyaert. 2001. Functional redundancy of the zinc fingers of A20 for inhibition of NF-κB activation and protein-protein interactions. FEBS Lett. 498:93.
36. Evans, P. C., E. R. Taylor, J. Coadwell, K. Heyninck, R. Beyaert, and P. J. Kilshaw. 2001. Isolation and characterization of two novel A20-like proteins. Biochem. J. 357:617.
37. Huang, J., L. Teng, L. Li, T. Liu, L. Li, D. Chen, L. G. Xu, Z. Zhai, and H. B. Shu. 2004. ZNF216 is an A20-like and IκB kinase γ-interacting inhibitor of NFκB activation. J. Biol. Chem. 279:16847.